TY  - JOUR
AU  - Rodriguez-Vida, Alejo
AU  - Rodríguez-Alonso, Andrés
AU  - Useros-Rodríguez, Eduardo
AU  - Lopez-Campos, Fernando
AU  - Amor-Carro, Oscar
AU  - Arribas-Ruiz, Alberto
AU  - Martinez-Torres, Javier
AU  - Roca-Pardiñas, Javier
AU  - Quesada-García, Alba
AU  - Muñoz-Del-Toro, Jacobo R
AU  - Juárez-Soto, Álvaro
PY  - 2021
DO  - 10.1016/j.clgc.2021.11.008
UR  - http://hdl.handle.net/10668/22103
T2  - Clinical genitourinary cancer
AB  - There was a high medical need for patients with non-metastatic castration-resistant prostate cancer (nmCRPC) when several next-generation anti-androgens (apalutamide, enzalutamide, and darolutamide) demonstrated clinically relevant delays in...
LA  - en
KW  - Apalutamide
KW  - Darolutamide
KW  - Enzalutamide
KW  - Next-generation anti-androgens
KW  - Survival analysis
KW  - Androgen Antagonists
KW  - Androgen Receptor Antagonists
KW  - Humans
KW  - Immunotherapy
KW  - Male
KW  - Proportional Hazards Models
KW  - Prostatic Neoplasms, Castration-Resistant
TI  - Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis.
TY  - research article
VL  - 20
ER  -